South Korea - Global health
At a glance
Global health is one of South Korea’s five priority issues; focus on an effective COVID-19 response
South Korea spent 9% (US$237 million) of its total official development assistance (ODA) on global health in 2019, according to the Organisation for Economic Cooperation and Development (OECD) Development Assistance Committee (DAC). A large proportion of these funds were channeled through bilateral contributions (79%; US$188 million), including earmarked funding to multilaterals which accounted for 14% or US$34 million, down from 18% or US$41 million in 2018). Bilateral funding in 2018 and 2019 remained relatively stable. Multilateral funding accounted for 21% (US$49 million) of total ODA to health, a considerable increase from 2018 when multilateral funding only accounted for 15% (US$34 million), but still well below the DAC average of 50%.
The main recipients of South Korea’s multilateral ODA to health in 2019 were the International Development Association of the World Bank (IDA; US$27 million), the World Health Organization (WHO; US$6 million), the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund; US$5 million), and Gavi, the Vaccine Alliance (Gavi; US$4 million).
The COVID-19 crisis dramatically reshaped the South Korean global health funding landscape and South Korea’s broader endeavor to increase its influence as a middle-power country. South Korea was invited to the G7 summit as a guest nation in June of 2021 where it pledged a historic US$200 million to the Gavi COVAX Advance Market Commitment (AMC); a significant increase from the previous pledge of US$10 million in 2020. The pledge allocates US$100 million for 2021 and an additional US$100 million in financial and in-kind contributions for 2022 to expand vaccine supply to lower-income countries.
South Korea made two major pledges for the 2020-2022 period, pledging US$25 million to the Global Fund at its sixth replenishment to fight AIDS, tuberculosis and malaria, and US$9 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate vaccines developments of emerging infectious diseases with epidemic potential and enable equitable access to vaccines in lower-income countries. South Korea contributed an additional US$1 million to Unitaid in 2020 to increase access to COVID-19 diagnostics through the Diagnostic Partnership of the Access to COVID-19 Tools Accelerator (ACT-A). South Korea joined ACT-A as a Facilitation Council member, providing strategic advice and guidance to ACT-A, and is one of eight countries — with the US, China, India, Russia, Brazil, Indonesia, South Africa, and Mexico — in the 'market leader group'.
South Korea’s funding to Gavi AMC, the Global Fund, CEPI, and ACT-A have dramatically increased over the courses of the pandemic, but funding from the Global Disease Eradication Fund (GDEF, a government program that aims to prevent and eradicate infectious diseases in partner countries) suffered significant losses. GDEF funds are raised through taxation on international flights departing from Korea. In the past, South Korea has supported several projects of multilateral organizations with GDEF funding, but limited travel during lockdown directly impacted its resource levels, with financing shrinking by 36% from KRW63.2 billion (US$54 million) in 2020 to KRW40.7 billion (US$35 million) in 2021. GDEF funding to multilaterals decreased by 73% between 2020 and 2021 from KRW31.2 billion (US$27 million) to KRW8.3 billion (US$7 million).
Global health is a priority issue in the ‘Mid-term Strategy for Development Cooperation (2021-2025)’ and has grown in importance due to the COVID-19 crisis. South Korea has set out the following multipronged approach until 2022: 1) ODA to health to increase by 21% from KRW277.3 billion (US$238 million) in 2020 to KRW335.8 billion (US$288 million) in 2021, 2) minimizing the impact of COVID-19 in partner countries; 3) strengthening and developing the health and medical systems of partner countries; 4) building the infectious disease response capacity in partner countries; and 5) enhance South Korea’s contributions by leveraging the solidarity groups for global health security that it leads in the UN, WHO, and UNESCO, and building partnerships with civil society organizations, private sector, research institutions, and philanthropic organizations. It will focus on developing therapeutics, providing training, and establishing healthcare facilities. It also seeks to further expand on the linkages between its foreign policies, such as the New Northern Policy and New Southern Policy, and its policies on development cooperation. The New Northern Policy and New Southern Policy serve to elevate ties with partner countries situated north and south of the Korean peninsula (see ‘Strategic Priorities’).
The Ministry of Foreign Affairs Development Cooperation Bureau leads on development of global health policy
South Korea’s global health policy is largely determined by the Ministry of Foreign Affairs (MOFA). Within MOFA, the Development Policy Division leads on developing global health policies. The Multilateral Development Cooperation and Humanitarian Assistance Division manages relations with multilateral health initiatives such as the Global Fund and Gavi.
The Ministry of Health and Welfare (MOHW) and the Korea Foundation for International Healthcare are also engaged in improving global health. Their global health programs include medical and healthcare assistance programs, including the provision of medical devices, equipment, and disaster relief. MOHW is responsible for the core and voluntary contributions to the WHO.